心脏骤停后保守与较高氧疗目标:系统评价、荟萃分析与试验序贯分析
该系统评价与荟萃分析纳入11项RCT(12篇报告)、4136例成人心脏骤停ROSC后接受侵入性机械通气的患者,比较保守氧疗与较高氧疗目标。保守氧疗组全因死亡率(RR 0.96,95%CI 0.88-1.06)和不良神经结局(RR 0.96,95%CI 0.88-1.04)均无显著差异;多数亚组分析无显著差异,仅严格低温(33°C-34°C)亚组死亡率降低,但TSA显示证据不稳定。保守氧疗增加低氧血症风险(RR 1.65)但改善无呼吸机天数(MD 2.14)。作者认为在当前常温(36°C-37.5°C)方案下,保守氧疗的累积证据趋向无效,但确定性信息量尚未完全累积。
要点
- 成人心脏骤停ROSC后侵入性机械通气患者,保守氧疗与较高氧疗在全因死亡率上无显著差异(RR 0.96,95%CI 0.88-1.06)。
- 不良神经结局同样无显著差异(RR 0.96,95%CI 0.88-1.04),多数亚组分析无显著差异。
- 保守氧疗增加低氧血症风险(RR 1.65),但改善无呼吸机天数(MD 2.14)。
- 仅严格低温(33°C-34°C)亚组显示死亡率降低,但试验序贯分析提示该证据不稳定。
- 当前常温(36°C-37.5°C)方案下,保守氧疗的累积证据趋向无效,但确定性信息量尚未完全累积。
适用人群与场景
- 成人心脏骤停患者,恢复自主循环(ROSC)后接受侵入性机械通气者。
- 纳入标准:仅限RCT,比较保守氧疗与较高氧疗对成人CA患者的影响。
诊断标准与关键阈值
- 原文未提及具体的氧疗目标阈值或诊断标准。
- 亚组分析涉及严格低温(33°C-34°C)与当前常温(36°C-37.5°C)方案。
处置流程与药物剂量
- 原文未提及具体的氧疗目标值、给药方式或调整流程。
红旗征与不能漏的情况
- 保守氧疗增加低氧血症风险(RR 1.65),需警惕低氧血症发生。
研究设计与关键结果
- 研究类型:系统评价、荟萃分析与试验序贯分析,遵循PRISMA 2020方案,检索至2026年6月。
- 纳入11项RCT(12篇报告),共4136例成人心脏骤停ROSC后侵入性机械通气患者。
- 保守氧疗 vs 较高氧疗:全因死亡率无显著差异(RR 0.96,95%CI 0.88-1.06)。
- 不良神经结局无显著差异(RR 0.96,95%CI 0.88-1.04)。
- 多数亚组分析无显著差异,仅严格低温(33°C-34°C)亚组死亡率降低,但TSA显示证据不稳定。
- 次要结局无显著差异;保守氧疗增加低氧血症风险(RR 1.65),改善无呼吸机天数(MD 2.14)。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,仅纳入RCT。
- 使用RoB 2评估偏倚风险,GRADE工具评估证据质量。
- 局限性:原文指出确定性信息量尚未完全累积;严格低温亚组证据经TSA显示不稳定。
对床旁实践的改变
- 在当前常温(36°C-37.5°C)方案下,保守氧疗的累积证据趋向无效,不支持常规采用保守氧疗以改善死亡率或神经结局。
- 若采用保守氧疗,需警惕低氧血症风险增加(RR 1.65),但可能改善无呼吸机天数(MD 2.14)。
- 严格低温(33°C-34°C)亚组的死亡率降低证据不稳定,不能作为决策依据。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Acad Emerg Med . 2026 Oct;33(10):e70422. doi: 10.1111/acem.70422. ABSTRACT BACKGROUND: Optimal oxygenation following return of spontaneous circulation (ROSC) remains uncertain, as both hypoxemia and hyperoxemia risk secondary injury. We conducted an updated systematic review and meta-analysis comparing the efficacy of restrictive versus higher oxygenation targets. METHODS: A systematic review and meta-analysis following the PRISMA 2020 protocol was carried out from database inception through June 2026. Only RCTs examining the impact of restrictive oxygenation versus higher oxygenation for adult CA patients undergoing invasive mechanical ventilation were included. Risks of bias and the quality of the evidence were evaluated using RoB 2 and GRADE tools. A random-effects model was used for data synthesis and presented the results in RR/MD. RESULTS: Eleven RCTs (12 reports) involving 4136 participants were included. Restrictive oxygenation showed no significant difference in all-cause mortality (RR 0.96, 95% CI 0.88-1.06) or unfavorable neurological outcomes (RR 0.96, 95% CI 0.88-1.04). Most subgroup analyses were non-significant, except for reduced mortality in the strict hypothermia subgroup (33°C-34°C), although TSA showed unstable evidence. No significant differences were observed in secondary outcomes. Restrictive oxygenation increased hypoxemia risk (RR 1.65) but improved ventilator-free days (MD 2.14). CONCLUSION: There is no significant improvement in overall mortality, neurological outcome, or any other major clinical endpoint in adult CA patients with restrictive oxygen compared to higher oxygen therapy. Under current normothermia (36°C-37.5°C) protocols, the accumulated evidence trends toward futility for a restrictive approach, though the definitive information size has not yet been entirely accrued. Although restrictive levels could lead to an increased number of ventilator-free days, there will be an increased risk of hypoxemia. PMID: 42872895 | DOI: 10.1111/acem.70422
参考来源
- PubMed · Acad Emerg Med:Conservative Versus Higher Oxygen Targets Post-Cardiac Arrest: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。